logo
Select company
Select metric
$ -10.7MInvested Capital
VS
Market
2
Sector
3
Industry
4
History
5
$ 0.74Close
$ 0.27 - $ 2.37 52-Week Range
Ticker Information

Ticker

BCAB

Company Name

BIOATLA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BIOATLA INC - Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCAB - Inv. Capital Historical data
DateTotal DebtShareholders EquityInvested Capital
6/30/2025$ 6.04M$ -16.75M$ -10.7M
3/31/2025$ 554K$ 547K$ 1.1M
12/31/2024$ 836K$ 14.27M$ 15.1M
9/30/2024$ 1.25M$ 22.97M$ 24.22M
6/30/2024$ 1.66M$ 31.37M$ 33.03M
3/31/2024$ 1.92M$ 49.72M$ 51.64M
12/31/2023$ 2.46M$ 70.67M$ 73.13M
9/30/2023$ 2.85M$ 94.7M$ 97.55M
6/30/2023$ 3.23M$ 124.52M$ 127.75M
3/31/2023$ 3.61M$ 156.43M$ 160.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOATLA INC's latest trailing twelve months (TTM) Inv. Capital stands at $ -73.84M.
  • Over the past 5 years, BIOATLA INC's average Inv. Capital has been $ 111.39M.
  • The median Inv. Capital for BIOATLA INC during this period was $ 137.36M
  • BIOATLA INC reached its highest Inv. Capital over the past 5 years at $ 230.65M.
  • The lowest Inv. Capital recorded by BIOATLA INC in the same timeframe $ -73.84M

BIOATLA INC's Inv. Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. Capital Benchmarks
CompanyInv. Capital
CRIS : CURIS INC $ -11.68MCARM : CARISMA THERAPEUTICS INC $ -44.3MCSCIF : COSCIENS BIOPHARMA INC $ 9.36MNXGL : NEXGEL INC $ 7.33MMRKR : MARKER THERAPEUTICS INC $ 10.49MNRXS : NEURAXIS INC $ 4.66MHCTI : HEALTHCARE TRIANGLE INC $ 10.62MLPCN : LIPOCINE INC $ 17.13MJAGX : JAGUAR HEALTH INC $ 38.52MDYAI : DYADIC INTERNATIONAL INC $ 4.53M

Definition of Invested Capital

[Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
Debt + Equity
(=) Inv. Capital
Inv. Capital for BIOATLA INC is calculated as follows: Debt [ $ 682K ] + Equity [ $ -74.52M ]
(=) Inv. Capital [ $ -73.84M ]

BCAB - Invested Capital, Last 5 years

$ -73.84M

Minimum

Sep 30, 2020

$ 230.65M

Maximum

Sep 30, 2021

$ 111.39M

Average

$ 137.36M

Median

Inv. Capital Benchmark Analysis

The chart above depicts the distribution of Inv. Capital for companies in the Total Stock Market. The average Inv. Capital of the companies is $ 760.7M with a standard deviation of $ 1B.
The following table provides additional summary stats:
Inv. Capital in the Market:
filtered constituents3.44K
min$ -1.51B
max$ 4.11B
average$ 760.7M
median$ 303.53M
std$ 1B